Try our Advanced Search for more refined results

Expert Analysis

2 Anti-Kickback Developments Hold Lessons For Biopharma

By Mary Kohler ( February 13, 2025, 6:25 PM EST) -- Last year ushered in new Anti-Kickback Statute concerns for biopharma companies after Ultragenyx Pharmaceutical Inc. paid $6 million to settle U. S. Department of Justice allegations about its free genetic testing program in late 2023. [1] As the industry asked why, prosecutors warned of more to come. [2] At year-end, they delivered. . . .

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

The 2025 AI Survey

Law firms are actively looking for ways to incorporate artificial intelligence into their workflow as it becomes ever more common. More than half of surveyed attorneys at U.S. law firms use generative AI for some purpose — up significantly from less than a third of attorneys who participated in the Law360 Pulse AI Survey last year.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!